274 related articles for article (PubMed ID: 17634421)
1. Angiopoietin: a TIE(d) balance in tumor angiogenesis.
Shim WS; Ho IA; Wong PE
Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421
[TBL] [Abstract][Full Text] [Related]
2. The role of the Angiopoietins in vascular morphogenesis.
Thomas M; Augustin HG
Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
4. How do angiopoietins Tie in with vascular endothelial growth factors?
Saharinen P; Bry M; Alitalo K
Curr Opin Hematol; 2010 May; 17(3):198-205. PubMed ID: 20375888
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietins: a link between angiogenesis and inflammation.
Fiedler U; Augustin HG
Trends Immunol; 2006 Dec; 27(12):552-8. PubMed ID: 17045842
[TBL] [Abstract][Full Text] [Related]
6. The role of Ang/Tie signaling in lymphangiogenesis.
Wu X; Liu N
Lymphology; 2010 Jun; 43(2):59-72. PubMed ID: 20848993
[TBL] [Abstract][Full Text] [Related]
7. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis.
Thurston G
Cell Tissue Res; 2003 Oct; 314(1):61-8. PubMed ID: 12915980
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.
Fiedler U; Reiss Y; Scharpfenecker M; Grunow V; Koidl S; Thurston G; Gale NW; Witzenrath M; Rosseau S; Suttorp N; Sobke A; Herrmann M; Preissner KT; Vajkoczy P; Augustin HG
Nat Med; 2006 Feb; 12(2):235-9. PubMed ID: 16462802
[TBL] [Abstract][Full Text] [Related]
9. The dynamic roles of angiopoietins in tumor angiogenesis.
Yu Q
Future Oncol; 2005 Aug; 1(4):475-84. PubMed ID: 16556024
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietins in malignancy.
Bach F; Uddin FJ; Burke D
Eur J Surg Oncol; 2007 Feb; 33(1):7-15. PubMed ID: 16962282
[TBL] [Abstract][Full Text] [Related]
11. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism.
Scharpfenecker M; Fiedler U; Reiss Y; Augustin HG
J Cell Sci; 2005 Feb; 118(Pt 4):771-80. PubMed ID: 15687104
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-Tie signaling in kidney diseases: an updated review.
He FF; Zhang D; Chen Q; Zhao Y; Wu L; Li ZQ; Zhang C; Jiang ZH; Wang YM
FEBS Lett; 2019 Oct; 593(19):2706-2715. PubMed ID: 31380564
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
14. Tie-1: A potential target for anti-angiogenesis therapy.
Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between the expression of angiopoietins and their receptor and angiogenesis in gastric cancers].
Zhang ZZ; Zhang S; Lin JY; Huang PS; Chen YP
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):280-4. PubMed ID: 16875629
[TBL] [Abstract][Full Text] [Related]
16. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta.
Seval Y; Sati L; Celik-Ozenci C; Taskin O; Demir R
Placenta; 2008 Sep; 29(9):809-15. PubMed ID: 18675456
[TBL] [Abstract][Full Text] [Related]
17. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.
Eklund L; Olsen BR
Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietins in tumours: the angiogenic switch.
Tait CR; Jones PF
J Pathol; 2004 Sep; 204(1):1-10. PubMed ID: 15307132
[TBL] [Abstract][Full Text] [Related]
19. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
